Vaccine Adjuvant: Adju-Phos®

Product description

Adju-Phos® is a range of aluminium phosphate gel products which have been specifically developed for use as an adjuvant in vaccines
The gel is a suspension of hydrated amorphous aluminium hydroxyphosphate nano/micron size crystal in loose aggregates. Adju-Phos products have a net negative charge at neutral pH and effectively adsorb positively charged antigens
The primary purpose of the adjuvant in vaccines is to boost the antibody-mediated (Th2) immune response to the antigens
Adju-Phos products can be combined with other adjuvant types (such as monophosphoryl lipids) to achieve a balanced Th1/Th2 immune response
Adju-Phos is supplied in two variants with pH-values at ca. 6.5 and at ca. 5.0. Both variants contain 0.9% NaCl (saline) to reduce injection site discomfort
Adju-Phos is produced in classified clean rooms to prevent contamination, sterilised and aseptically filled in a grade A clean room.

Chemical Group

Aluminium oxyhydroxide
Administration Route

Vaccine Adjuvant

Market Application

Human vaccines
Veterinary vaccines

Functions

Vaccine Adjuvant

Physical Form

A gel-like aqueous suspension. A supernatant forms when the product is left idle.

Specifications

CAS Registry Number	7784-30-7
Categories	Intermediates, Fine and Specialty Chemicals; APIs (Active Pharmaceutical Ingredients)Sera and Vaccines; Intermediates, Fine and Specialty ChemicalsSpecialty Chemicals
Sales markets	Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from	Denmark

More products from Croda Europe Limited

Excipient: Super Refined™ PEG 400

Super Refined PEGs are solvents for use with the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes polar impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, reducing excipient...

More info

Excipient: Super Refined™ Polysorbate 80

Super Refined Polysorbates solubilise and stabilise the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, helping to reduce...

More info

Excipient: Super Refined™ CCMG 400

Super Refined CCMG 400 is a multi-compendial, high purity mixture of caprylocaproyl polyoxylglycerides. This product has undergone intense purification, by which impurities and other reactive species that could negatively impact API and formulation stability have been removed.

Pharmacopoeia ...

More info

Vaccine Adjuvant: QS-21

• Quillaja saponaria Molina is a South American tree native to Chile whose bark is rich in a complex mixture of triterpenic saponins • Quillaja-derived saponins such as Quil-A® are currently used as veterinary vaccine adjuvants • One specific fraction of the Quil-A saponin mixture, QS-21, is an extreme...

More info

Super Refined™ Pharmaceutical Excipients for Parenteral Applications

The formulation of active pharmaceutical ingredients (APIs) for parenteral applications demands the highest quality standards and attention to detail. Excipient selection is critical to drug stability, formulation integrity and patient safety.
Croda’s Super Refined™ excipients offer multiple benefit...

More info